NIH spending for drugs approved 2010-2019 lower than industry spending, study finds
European Pharmaceutical Review
JULY 17, 2023
New research published in JAMA Health Forum has documented that the US National Institutes of Health (NIH) spent $8.1 billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. This was ~10 percent of reported industry spending. billion (3.3
Let's personalize your content